Results 31 to 40 of about 211 (73)

Combinatorial Treatment of Birinapant and Zosuquidar Enhances Effective Control of HBV Replication In Vivo. [PDF]

Viruses, 2020
Morrish E, Mackiewicz L, Silke N, Pellegrini M, Silke J, Brumatti G, Ebert G.   +6 more
europepmc   +1 more source

Asenapine versus olanzapine for the treatment of nausea and vomiting in patients with cancer: A retrospective study. [PDF]

Neuropsychopharmacol Rep
Kimura T, Kanai A, Muraoka H, Takahashi Y, Ara M, Inada K.   +5 more
europepmc   +1 more source

The NLRP3 inhibitor Dapansutrile improves the therapeutic action of lonafarnib on progeroid mice. [PDF]

Aging Cell
Muela-Zarzuela I, Suarez-Rivero JM, Boy-Ruiz D, López-Pérez J, Sotelo-Montoro M, Del Mar Navarrete-Alonso M, Collado IG, Botubol-Ares JM, Sanz A, Cordero MD.   +9 more
europepmc   +1 more source

Osteopathy students profile in Italy: A cross sectional census. [PDF]

PLoS One, 2021
Consorti G, Bagagiolo D, Buscemi A, Cicchitti L, Persiani M, Bergna A, OSA Group.   +6 more
europepmc   +1 more source

Baricitinib and Lonafarnib Synergistically Target Progerin and Inflammation, Improving Lifespan and Health in Progeria Mice. [PDF]

Int J Mol Sci
Krüger P, Schroll M, Fenzl FQ, Hartinger R, Lederer EM, Görlach A, Gordon LB, Cavalcante P, Iacomino N, Rathkolb B, Pimentel JAA, Östereicher M, Spielmann N, Wolf CM, de Angelis MH, Djabali K.   +15 more
europepmc   +1 more source

Optimal dose for the efficacy of asenapine in patients with schizophrenia: Real-world data. [PDF]

Neuropsychopharmacol Rep
Takekita Y, Hiraoka S, Iwama Y, Matsui D, Aoki N, Ogata H, Funatsuki T, Shimizu T, Murase Y, Koshikawa Y, Kato M, Kinoshita T.   +11 more
europepmc   +1 more source

Effect of single-administration of D-sorbitol pretreatment on the bitterness and continued willingness to take asenapine: a randomized, single-blind, placebo-controlled, crossover trial. [PDF]

BMC Psychiatry
Wada S, Iwamoto K, Okumura H, Hida H, Hiraoka S, Kamei A, Mori D, Yamada K, Ando M, Ozaki N, Ikeda M.   +10 more
europepmc   +1 more source

In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions. [PDF]

Pharmacol Rep, 2020
Wójcikowski J, Danek PJ, Basińska-Ziobroń A, Pukło R, Daniel WA.   +4 more
europepmc   +1 more source

Therapeutic potential for P2Y₂ receptor antagonism. [PDF]

Purinergic Signal, 2023
Jasmer KJ, Muñoz Forti K, Woods LT, Cha S, Weisman GA.   +4 more
europepmc   +1 more source

In Vitro synergy of Farnesyltransferase inhibitors in combination with colistin against ESKAPE bacteria. [PDF]

PLoS One
Klose M, Weber L, Bachmann HS.
europepmc   +1 more source